Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery.
Ontology highlight
ABSTRACT: Safer and more-effective drugs are urgently needed to counter infections with the highly pathogenic SARS-CoV-2, cause of the COVID-19 pandemic. Identification of efficient inhibitors to treat and prevent SARS-CoV-2 infection is a predominant focus. Encouragingly, using X-ray crystal structures of therapeutically relevant drug targets (PLpro, Mpro, RdRp, and S glycoprotein) offers a valuable direction for anti-SARS-CoV-2 drug discovery and lead optimization through direct visualization of interactions. Computational analyses based primarily on MMPBSA calculations have also been proposed for assessing the binding stability of biomolecular structures involving the ligand and receptor. In this study, we focused on state-of-the-art X-ray co-crystal structures of the abovem
SUBMITTER: Wang Z
PROVIDER: S-EPMC8373586 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA